Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $11.55
Used from: $2.64

Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
by Stewart Justman
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $12.78
Used from: $12.78

Prostate Cancer For Dummies
Prostate Cancer For Dummies
by Paul H. Lange Christine Adamec Christine Adamec
Our Price: $14.80
Used from: $0.01

The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
by Dr. Aaron Katz
Our Price: $11.55
Used from: $5.57



Hormone Refractory Prostate Cancer Links


<< 1 2 3 >>




Hormone Refractory Prostate Cancer Headlines


Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society ... - MarketWatch (press release)


Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society ...
MarketWatch (press release)
PROVENGE is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. PROVENGE is intended solely for autologous use and is not ...

and more »

Read more...


Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society ... - MarketWatch (press release)


Live Trading News

Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society ...
MarketWatch (press release)
PROVENGE is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. PROVENGE is intended solely for autologous use and is not ...
Provenge And NeuVax: A Tale Of 2 MarvelsSeeking Alpha

all 34 news articles »

Read more...